Klivira
Request demo

Streamlining Medicare Kesimpta Prior Authorization

Navigating Medicare Kesimpta prior authorization is a critical challenge for revenue cycle and prior authorization teams. Klivira provides a robust solution to automate and accelerate these complex submissions.

Kesimpta (ofatumumab) is a high-volume prior authorization target across various payer types, including Medicare Advantage and Medicaid managed care plans. For Original Medicare beneficiaries, understanding the specific pathways and requirements for specialty medications like Kesimpta is crucial for ensuring timely patient access and optimizing revenue cycles. This page outlines the specific considerations for Medicare Kesimpta prior authorization.

Understanding Kesimpta and Medicare Prior Authorization Dynamics

Kesimpta, an anti-CD20 monoclonal antibody, is indicated for the treatment of relapsing forms of multiple sclerosis (RMS) in adults. As a high-cost specialty medication, Kesimpta typically requires prior authorization to ensure medical necessity and appropriate utilization. Under Medicare, these requirements vary significantly between Original Medicare (Fee-for-Service) and Medicare Advantage (MA) plans, necessitating a nuanced approach to PA submissions.

Navigating Medicare's Prior Authorization Landscape for Specialty Medications

Original Medicare's prior authorization scope is generally limited to specific services, such as certain Outpatient Department services, Durable Medical Equipment (DME), and particular home health or ambulance transport. For specialty drugs like Kesimpta, coverage typically falls under Medicare Part D. Prior authorization for services covered under Original Medicare Part A and B, where applicable, routes through the responsible Medicare Administrative Contractor (MAC) for the provider's jurisdiction, each with its own submission specifics.

Medicare Part D and Pharmacy Prior Authorization for Kesimpta

Medicare Part D plans, operated by private commercial insurers, administer pharmacy prior authorization for medications like Kesimpta. These plans adhere to CMS-approved formularies and may implement step-therapy protocols or quantity limits. Klivira's platform is designed to integrate with the various submission channels utilized by Part D plans, including electronic prior authorization (ePA) via NCPDP SCRIPT standards where available, to streamline these complex pharmacy benefit submissions.

Accessing Utilization Management Policies: NCDs and LCDs

Prior authorization decisions for Medicare-covered services are guided by National Coverage Determinations (NCDs) published by CMS and Local Coverage Determinations (LCDs) issued by the responsible MAC for each jurisdiction. While NCDs and LCDs primarily apply to Part A and B services, understanding their framework is crucial for any Medicare PA. Klivira's policy logic incorporates NCD and LCD awareness to align submissions with payer requirements.

Klivira's Approach to Streamlining Medicare Kesimpta Prior Authorization

Klivira automates the prior authorization process for specialty drugs like Kesimpta by providing MAC-aware routing for Original Medicare services and robust connectivity to Medicare Part D plans. Our platform integrates with your EMR via SMART on FHIR, extracting necessary clinical data and populating X12 278 transactions or payer-specific portals. This reduces manual effort, accelerates submission, and enhances the consistency of your prior authorization workflows.

Key Medicare Administrative Contractors (MACs) for Prior Authorization

  • Noridian Healthcare Solutions
  • NGS Medicare
  • WPS GHA
  • Palmetto GBA
  • First Coast Service Options (FCSO)
  • Novitas Solutions

Frequently asked questions

Which part of Medicare typically covers Kesimpta?

Kesimpta is generally covered under Medicare Part D, which handles prescription drug benefits. Medicare Part D plans are administered by private insurers and have their own formularies and prior authorization requirements. Original Medicare (Parts A and B) primarily covers medical services and supplies, not outpatient prescription drugs.

What is the role of Medicare Administrative Contractors (MACs) in Kesimpta prior authorization?

MACs primarily handle prior authorization for services covered under Original Medicare Part A and B, where PA is required (e.g., certain DME or outpatient services). For Kesimpta, as a Part D drug, MACs are not directly involved in the drug's prior authorization. However, understanding MAC jurisdictions is vital for providers submitting any Part A/B PAs.

Are National Coverage Determinations (NCDs) and Local Coverage Determinations (LCDs) relevant to Kesimpta PA?

NCDs and LCDs provide coverage criteria for services under Original Medicare Part A and B. While they do not directly dictate prior authorization for Part D drugs like Kesimpta, they establish a framework for medical necessity that can indirectly influence Part D plan policies. Klivira's system is built with awareness of these policy types.

How does Klivira address the specific requirements of Medicare Part D plans for Kesimpta?

Klivira connects to Medicare Part D plans through various channels, including ePA via NCPDP SCRIPT and direct portal integrations. Our platform automates the extraction of clinical data from your EMR and populates the necessary forms, ensuring submissions align with plan-specific formularies, step-therapy protocols, and other utilization management criteria.

Does CMS-0057-F impact Kesimpta prior authorization under Original Medicare?

The CMS-0057-F rule primarily impacts Medicare Advantage, Medicaid managed care, CHIP, and qualified health plans on the federal exchange. Its applicability to prior authorization under Original Medicare (Fee-for-Service) is limited. Therefore, while it sets important standards for other lines of business, its direct influence on Kesimpta PA under Original Medicare is minimal.

Related coverage

Other kesimpta prior authorization by payer

Other kesimpta prior authorization by specialty

Ready to automate prior auth for this drug?

See how Klivira automates prior authorizations for your team.

Request a demo